Archive for 'Health2.0' Category:

Thumb nail
By David Robinson: Thursday 18th August, 2016

ASSIS – A virtual assistant concept to help you take your medication

The objects in our lives are changing, fast. They are getting smarter and our relationship with them has shifted. Last night I asked my phone – just by speaking to it – to set an alarm, which still amazes me. With new technological advancements like this, society is on the cusp of vast change. All […]

Mobile Ecosystem
By Vaishali Kamat: Monday 17th August, 2015

Technology could save the NHS Billions!

The last decade has seen a staggering 60% increase in the incidence of Diabetes in the UK and the NHS is apparently picking up a £10Billion tab for Diabetes related costs each year.  And this is only going to increase unless some drastic measures are taken to prevent and manage the disease – and quickly. […]

weighing machine from a sea pebble
By Dean Griffiths: Tuesday 2nd June, 2015

Supplying the demand for precision medicine

Supply and demand is one of the fundamental concepts in economics; in a market economy supply and demand theory suggests resources will be allocated in the most efficient way possible.  The inexorable rise in the demand for healthcare and the ever-increasing costs associated with the supply of new therapies has meant that understandably, a true […]

Innovative technology
By Dean Griffiths: Tuesday 3rd March, 2015

Three innovation trends in life sciences

Successful products meet the needs of customers; brands including Apple, Gucci and Porsche can create needs, however for most brands, successful products delight customers by fulfilling pre-existing unmet needs. The diversity of needs across the life sciences research market is significant.  Researchers are looking to uncover the molecular mechanisms underpinning questions which vary from neurodegeneration, […]

data flow
By Dean Griffiths: Tuesday 13th January, 2015

Product bundling for DNA sequencing

Roche recently announced that they have made another move in the DNA sequencing space; Roche will spend $1.03 billion to buy a 56.3% stake in Foundation Medicine. This comes after other recent moves which have seen Roche acquire Genia Technologies and Ariosa Diagnostics. In growing its’ portfolio Roche is highlighting the importance of two things; […]

milife band
By Simon Attard: Wednesday 18th June, 2014

Wearable technology; moving beyond activity tracking

A few days ago, some members of the medical software group had the opportunity to attend a workshop on healthcare wearable technology organised by imec and the National Institute for Health Research. During this event we discussed the current state of the wearable technology industry, what challenges are currently being faced and some important tips […]

DNA
By Dean Griffiths: Monday 2nd June, 2014

Sequencing; will DNA analysis have any other name?

The analysis of nucleic acids is increasingly at the heart of the care pathway for patients with a myriad of different diseases.  Diagnosis of many diseases from cancer to flu increasingly relies upon an analysis of the nucleic acids present in a sample.  The question I get asked most frequently when I talk with in […]

Drug Delivery
By Dean Griffiths: Friday 23rd May, 2014

Cancer therapies; cost, price and value

A plethora of data demonstrating the efficacy of new cancer therapies will be released at the upcoming American Society for Clinical Oncology (ASCO).  Data are expected from Roche, Merck, Bristol-Myers Squibb about their immuno-oncology therapies but the most hotly debated topic may be the introduction of an ASCO scorecard which will rate therapies not just […]

Single cell balance
By Dean Griffiths: Thursday 15th May, 2014

Single cell analysis; learning more from individuals than crowds

Genomics, proteomics, transcriptomics, epigenomics and many others large scale tools have been driving the economics of life science research for a number of years.  These technologies have provided insight into many of the mechanisms which control how cells and tissues function.  However these technologies are often hindered by their requirements for a large quantity of […]

Cancer cells
By Dean Griffiths: Friday 14th February, 2014

3 innovations which will help fight cancer

A global “tidal wave” of cancer has been predicted by The World Health Organisation.  Cancer already costs the global economy more than $1.1 trillion annually and that number looks set to significantly increase.  At Cambridge Consultants we have been looking at how innovations in healthcare products and service will change the cancer treatment landscape. Monetise […]